D&A Journal cover

ADAA members receive a complimentary annual online subscription to Depression and Anxiety. With an impact factor of 5.004, this journal ranks 19 of 140 in psychiatry journals and 10 of 76 in psychology journals.

Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online only as of January 2013. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.

A priority is placed on papers focusing on treatment, as well as those providing cutting-edge reviews of key areas and issues, in order to enhance the clinical evaluation and care of individuals struggling with the effects of these disorders. All submissions are peer-reviewed; there is no handling or publishing fee.

NOTE: You must be a current member to log in. If you have questions about your login, please contact ADAA Membership.

Please note: Three open-access journals, the Journal of Depression & Anxiety (OMICS); Anxiety and Depression Research (Herbert Publications); and Annals of Depression and Anxiety (Austin Publishing) are not affiliated with ADAA. These publishers require payment of a handling or submissions fee from authors; find information about these fees on their websites. These publications are not related to Depression and Anxiety, the official ADAA journal.

The following articles from Volume 33 Issue 9 (September 2016) have been posted on the journal website.

Letter

From the ADAA President
Karen Lynn Cassiday PhD, ACT, President, ADAA

Research Article

Psychotherapy versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments
Daniel J. Lee MD, Carla W. Schnitzlein DO, Jonathan P. Wolf MD, Meena Vythilingam MD, Ann M. Rasmusson MD, Charles W. Hoge MD

Patterns of Change in Response to Prolonged Exposure: Implications for Treatment Outcome
Joshua D. Clapp PhD, Joshua J. Kemp MS, Keith S. Cox PhD, Peter W. Tuerk PhD

Individualized Yoga for Reducing Depression and Anxiety, and Improving Well-Being: A Randomized Controlled Trial
Michael de Manincor, Alan Bensoussan, Caroline A. Smith, Kylie Barr, Monica Schweickle, Lee-Lee Donoghoe, Suzannah Bourchier, Paul Fahey

A Brief Ecological Momentary Intervention for Generalized Anxiety Disorder: A Randomized Controlled Trial of the Worry Outcome Journal
Lucas S. LaFreniere BA, Michelle G. Newman PhD


The following articles from Volume 33 Issue 8 (August 2016) have been posted on the journal website.

Letter

From the ADAA President
Karen Lynn Cassiday PhD, ACT, President, ADAA

Research Article

Childhood Maltreatment Predicts Reduced Inhibition-Related Activity in the Rostral Anterior Cingulate in PTSD, but not Trauma-Exposed Controls
Jennifer S. Stevens PhD, Timothy D. Ely BS, Takehito Sawamura MD, PhD, Dora Guzman BA, Bekh Bradley PhD, Kerry J. Ressler MD, PhD, Tanja Jovanovic PhD

Review

Ketamine's Mechanism of Action: A Path to Rapid-Acting Antidepressants
Chadi G. Abdallah MD, Thomas G. Adams PhD, Benjamin Kelmendi MD, Irina Esterlis PhD, Gerard Sanacora MD, PhD, John H. Krystal MD

Ketamine for Treatment-Resistant Unipolar and Bipolar Major Depression: Critical Review and Implications for Clinical Practice
William V. Bobo MD, MPH, Jennifer L. Vande Voort MD, Paul E. Croarkin DO, MSc, Jonathan G. Leung PharmD, Susannah J. Tye PhD, Mark A. Frye MD

Ketamine: A Potential Rapid-Acting Antisuicidal Agent?
Samuel T. Wilkinson MD, Gerard Sanacora MD, PhD

Editorial

Whither Ketamine as an Antidepressant: Panacea or Toxin?
D. Jeffrey Newport MD, MS, MDiv, Alan F. Schatzberg MD, Charles B. Nemeroff MD, PhD